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Abstract
Background: Hormone-sensitive lipase (HSL) is a key enzyme in the mobilization of fatty acids from stored triacylglycerols.
Its activity is regulated by reversible protein phosphorylation. In rat HSL Ser563, Ser659 and Ser660 have been shown to be
phosphorylated by protein kinase A (PKA) in vitro as well as in vivo.
Methodology/Principal Findings: In this study we employed site-directed mutagenesis, in vitro phosphorylation and mass
spectrometry to show that in vitro phosphorylation of human HSL by PKA occurs primarily on Ser649 and Ser650 (Ser659
and Ser660 in rat HSL). The wild type enzyme and four mutants were expressed in C-terminally His-tagged form in Sf9 insect
cells and purified to homogeneity. HSL variants in which Ser552 and/or Ser554 were mutated to Ala or Glu retained both
lipolytic and non-lipolytic activity and were phosphorylated by PKA and activated to a similar extent as the wild type
enzyme.
32P-labeling studies revealed that the bulk of the phosphorylation was on the Ser649/Ser650 site, with only a minor
phosphorylation of Ser552 and Ser554. MS/MS analysis demonstrated that the peptide containing Ser649 and Ser650 was
primarily phosphorylated on Ser650. The mutant lacking all four serines had severely reduced lipolytic activity, but a lesser
reduction in non-lipolytic activity, had S0.5 values for p-nitrophenol butyrate and triolein comparable to those of wild type
HSL and was not phosphorylated by PKA. PKA phosphorylation of the wild type enzyme resulted in an increase in both the
maximum turnover and S0,5 using the TO substrate.
Conclusions: Our results demonstrate that PKA activates human HSL against lipid substrates in vitro primarily through
phosphorylation of Ser649 and Ser650. In addition the results suggest that Ser649 and Ser650 are located in the vicinity of a
lipid binding region and that PKA phosphorylation controls the accessibility of this region.
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Introduction
Fatty acids mobilized from stored triacylglycerols are a major
energy source in humans. Mobilization occurs through the
consecutive action of three lipases: the recently discovered adipose
triglyceride lipase, hormone-sensitive lipase (HSL) and mono-
acylglycerol lipase. Whereas adipose triglyceride lipase and
monoacylglycerol lipase appear to be quite specific for triacylgly-
cerols and monoacylglycerols, respectively, HSL exhibits very
broad substrate specificity, hydrolyzing a wide range of substrates
including triacylglycerol, diacylglycerol, monoacylglycerol, choles-
teryl, retinyl, lipoidal and water-soluble esters. Accordingly, HSL
is expressed in several tissues in addition to white adipose tissue,
e.g. brown adipose tissue, skeletal muscle, steroidogenic tissues,
intestine, pancreatic b-cells and macrophages. Its role in each of
these tissues remains to be determined, but it seems clear that, in
addition to its role in fatty acid mobilization, HSL plays an
important role in lipid signalling events of importance for e.g.
spermatogenesis, adipogenesis and insulin secretion. Thus, HSL is
an important target for preventive and interventive actions in the
area of obesity and diabetes [1].
A major feature of HSL is its regulation by reversible protein
phosphorylation. Early work by Belfrage and others showed that
HSL was phosphorylated at two serines in what was later
designated the regulatory module of the enzyme [2,3,4,5,6].
One site was phosphorylated under basal conditions (the basal site)
and another was phosphorylated by protein kinase A (PKA) upon
stimulation of lipolysis (the regulatory site). In the rat enzyme these
phosphorylation sites correspond to Ser563 (regulatory site) and
Ser565 (basal site). The basal site has been reported to be
phosphorylated in vitro by several kinases, with AMP-activated
protein kinase (AMPK) as the most likely candidate in vivo [3,4]. It
has been suggested that phosphorylation of these two sites is
mutually exclusive due to steric hindrance. In vitro PKA
phosphorylation of recombinant HSL has been shown to increase
PLoS ONE | www.plosone.org 1 November 2008 | Volume 3 | Issue 11 | e3756the activity of the enzyme against triolein by 100% for the rat
enzyme and by somewhat less for the human enzyme [7,8].
During the last decade the phosphorylation events of rat HSL
have proven to be more complicated than originally reported, with
the demonstration that Ser659 and Ser660, in addition to Ser563,
are phosphorylated by PKA in vitro as well as in response to
lipolytic stimulation of rat adiopocytes. It was also found that
Ser659 and Ser660 were the major activity controlling sites in vitro,
whereas mutation of Ser563 has shown to be without effect with
regard to both in vitro activation by PKA [9] and translocation in
response to lipolytic stimulation of adipocytes [10]. In contrast,
another study reported that mutating Ser563 to Ala abolished all
HSL activity in vitro, indicating an important role for this residue in
the enzymatic activity of HSL [11]. The phosphorylation sites of
rat HSL are conserved in human HSL: Ser563, Ser565, Ser659
and Ser660 in the rat enzyme correspond to Ser552, Ser554,
Ser649 and Ser650 in the human enzyme [8]. However, to date
only a few studies have addressed the phosphorylation events in
human HSL. These have shown that human HSL is activated to a
lesser extent than rat HSL in vitro and have furthermore suggested
an important role for Ser650 in governing the activation in vivo
[8,12,13].
In this study we used site directed mutagenesis, in vitro
phosphorylation, titanium dioxide phosphopeptide enrichment
and mass spectrometry (MS) in combination with activity studies
to show that Ser649/Ser650 is the major determinant of activation
of human HSL by PKA in vitro and that phosphorylation alters the
kinetic behaviour of the enzyme with an increase in both the
maximum turnover rate and the S0.5 towards the trioleoin
substrate. Furthermore, we demonstrate that Ser649 and Ser650
are major determinants of the lipolytic activity but are of lesser




The previously described cDNA clone of human HSL [8] was
modified using a standard PCR-based mutagenesis protocol,
cloned into the pVL1393 shuttle vector from PharMingen (BD
Biosciences) and sequenced. Recombinant baculovirus was
generated using the Baculo-Gold kit (PharMingen) according to
the manufacturer’s protocol. Single virus particles were isolated
from the inoculum by plaque assay followed by the generation of
high titre virus stocks. The titres of these stocks were determined
by plaque assay. In total five variants of human HSL were
generated (listed in Table 1). Common to all variants was that a
proline residue followed by eight histidines was added to the
C-terminus to aid purification.
Expression and purification of HSL variants
Sf9 insect cells were grown at 27uC in suspension cultures
(160 rpm) in Sf-900 medium supplemented with 4% heat
inactivated foetal calf serum and 1% penicillin/streptomycin (all
from Gibco). For expression of HSL, cell cultures (2610
6 cells/
mL) were infected at a multiplicity of infection of 10 followed by a
72 h expression period. Cells were harvested by centrifugation and
resuspended in five pellet volumes of lysis buffer (20 mM Tris-HCl
pH 8.0, 1 mM DTT, 1 mM EDTA, 1% C13E12, 10% glycerol).
The cell suspension was gently sonicated and centrifuged for
45 min at 4uC and 50000 g. The supernatant fraction was filtered
through a 0.22 mm filter and loaded onto a Q-Sepharose Fast
Flow anion exchange column (GE Healthcare). The column was
washed with ten volumes of 50 mM NaCl, 20 mM Tris-HCl
pH 8.0, 1 mM DTT, 1 mM EDTA, 0.01% C8E4, 10% glycerol,
then eluted with approximately two column volumes of 1 M NaCl,
20 mM Tris-HCl pH 8.0, 0.1 mM DTT, 0.01% C8E4, 10%
glycerol.
Protein eluted from the Q-Sepharose column was loaded
directly onto a nickel affinity chromatography column (Ni-NTA
Superflow; Qiagen), washed with ten volumes of 18 mM
imidazole, 300 mM NaCl, 50 mM Tris-HCl pH 8.0, 0.1 mM
DTT, 1% Triton X100, 10% glycerol and 15 volumes of 5 mM
imidazole, 300 mM NaCl, 50 mM Tris-HCl pH 8.0, 0.1 mM
DTT, 0.01% C8E4, 10% glycerol and eluted with a stepwise
gradient towards 250 mM imidazole, 300 mM NaCl, 50 mM
Tris-HCl pH 8.0, 1 mM DTT, 0.01% C8E4, 10% glycerol. The
eluted protein was then dialysed overnight against 50 mM Tris-
HCl pH 8.0, 300 mM NaCl, 1 mM DTT, 0.01% C8E4 and 10%
glycerol and stored at –80uC. Protein amounts were measured by
the 2D Quant method (GE Healthcare) and the Bradford method
[14]. The latter underestimated HSL content by a factor of 1.5
relative to the 2D Quant method.
Tryptophan fluorescence measurements
Eight mg of purified protein was excited at 296 nm in 1 ml of
50 mM Tris-HCl pH 8.0, 1 mM DTT, 0.01% C8E4 and 10%
glycerol and emission was scanned from 300 nm to 400 nm in a
Fluoromax-2 fluorometer.
Detection of phosphorylation of HSL in insect cells
Tissue culture flasks were supplemented with 3610
6 Sf9 insect
cells in 5 ml Sf-900 medium at 27uC. After cell adhesion the
medium was removed and cells were infected at a MOI of 10. As a
negative control cells were infected with the BaculoGold kit
control virus. After infection for 1 h the inoculum was replaced by
4 ml fresh medium and incubated at 27uC. After approximately
60 h the medium was replaced with 2 ml of fresh medium
containing 0.1 mCi/mL
32PO4
32 (GE Healthcare) and incubated
for an additional hour. Medium was removed and cells were
gently rinsed twice with 4 ml of medium before they were scraped
in 1 ml of 300 mM NaAc, 20 mM Tris-HAc pH 8.0, 5% glycerol,
0.5 mM DTT, 10 mM imidazole and 1% C8E4. Cell suspensions
were transferred to Eppendorf tubes and placed at –20uC for 3 h
followed by thawing on ice. After thawing the lysed cells were
centrifuged for 20 min at 20000 g and 4uC. The supernatants
were transferred to fresh tubes, to which 300 ml of Ni-NTA
agarose were added and incubated at 4uC for 1 h, followed by
mild centrifugation and removal of the supernatant. The gel was
then washed twice with 1 ml of 300 mM NaAc, 20 mM Tris-HAc
pH 8.0, 5% glycerol, 0.5 mM DTT, 10 mM imidazole and 0.01%
C8E4. The protein was eluted by resuspending the gel in of 150 ml
of elution buffer consisting of 300 mM NaAc, 20 mM Tris-HAc
pH 8.0, 5% glycerol, 1 mM DTT, 250 mM imidazole and 0.01%
Table 1. Recombinant HSL variants
Variant Mutation
WT None
SVA-SS Ser 554 to Ala
SVE-SS Ser 554 to Glu
AVA-SS Ser 552 and Ser 554 to Ala
AVA-AA Ser 552 and Ser 554 to Glu
doi:10.1371/journal.pone.0003756.t001
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supernatant.
The eluted samples were then dialyzed overnight against
20 mM Tris-HAc pH 8.0, 10% glycerol, 1 mM DTT and
0.01% C8E4. The dialyzed samples were analyzed by SDS-PAGE,
stained with Coomassie Blue, scanned and slab dried.
32P-labeled
HSL was detected by digital imaging on a Fujix BAS-2000 (Fuji).
Image-Quant TL software (GE Healthcare) was used for
quantification of signals on gels.
Dephosphorylation and PKA phosphorylation of HSL
Six mg of HSL were dephosphorylated in 100 ml volumes
containing 80 ml of the above dialysis buffer, 10 U (1 U/ml) of calf
intestinal phosphatase, 10 ml of 1 mM Tris-HCl pH 8.0, 200 mM
MgCl2 supplemented with a cocktail of protease inhibitors (Roche
Complete). The dephosphorylation reaction was performed for
1 h at RT. The phosphatase was then inactivated by the addition
of 2 ml of 500 mM sodium orthovanadate. The subsequent PKA
phosphorylation was performed by mixing 50 ml of the dephos-
phorylation reaction mixture with 7 ml of 10x PKA buffer, 15 ml
10 mM ATP and 25 U PKA (New England Biolabs). In control
reactions PKA and ATP were omitted. For the detection of
incorporation of phosphate by PKA 3 ml[ c-P
32]ATP (10 mCi/
mmol) was added to the phosphorylation reaction mixture and
aliquots were taken after 5, 15 and 30 min of incubation and
quenched by the addition of Laemmli buffer [15]. Samples were
analyzed by SDS-PAGE, stained with Coomassie, scanned and
slab dried.
32P-labeled HSL was detected as described above. For
quantification of incorporated phosphate HSL, bands were excised
from the gel, placed in scintillation vials containing 10 ml of
scintillation liquid and quantified on a scintillation counter (Wallac
1414 liquid scintillation counter, Perkin Elmer). The original
reactions were included as standards.
Mass spectrometry analysis of phosphopeptides
The proteins were subjected to SDS-PAGE and protein bands
where excised from the gel and dried by lyophilisation. The
excised gel plug was washed in digestion buffer (50 mM
NH4HCO3, pH 7.8/acetonitrile (60/40)) and dried by vacuum
centrifugation. Modified trypsin (8 ng/ml) dissolved in 50 mM
NH4HCO3, pH 7.8 was added to the dry gel pieces and they were
incubated on ice for 1 h. After removing the supernatant
additional digestion buffer was added and the digestion was
continued at 37uC for 4–12 h.
The purification of phosphorylated peptides was performed
using titanium dioxide (TiO2) chromatography, essentially as
described previously [16,17]. An aliquot of the peptides derived
from the in-gel digest (5 ml, corresponding to 20%) was mixed with
35 ml TiO2 chromatography loading buffer (80% acetonitrile/5%
TFA/1 M glycolic acid [17]. The solution was applied to a TiO2
micro-column and the liquid was gently pressed through the
column using a fitted 1 ml plastic syringe. The column was washed
with 10 ml loading buffer and 20 ml 80% acetonitrile/1% TFA.
The bound phosphopeptides were eluted using ammonia water
pH 11.3 (10 ml ammonia (25%) in 490 ml UHQ water).
The purified phosphopeptides were lyophilized prior to nano-
liquid chromatography ESI-MSMS or further desalted on
reversed-phase micro-columns prior to MALDI MS analysis as
described previously [18].
MALDI mass spectrometry
MALDI MS was performed on a Bruker Ultraflex instrument
(Bruker Daltonics). All spectra were obtained in positive reflector
ion mode. The matrix used was 2.5-dehydroxybenzoic acid (DHB)
(20 mg/ml) in 50% acetonitrile, 0.1% TFA, 1% phosphoric acid
[19]. The spectra were processed using the flexAnalysis software
(Bruker Daltonics).
Nano-liquid chromatography tandem mass spectrometry
(nano-LC-MS)
The nano-LC-MS experiments were performed using an
Orbitrap XL mass spectrometer (Thermo Electron). The sample
was applied to an EASY nano-LC system (Proxeon Biosystems,
Odense, Denmark). The peptides were concentrated on a 1.0 cm
pre-column (75 mm inner diameter, 360 mm outer diameter,
ReproSil–Pur C18 AQ 3 mm (Dr. Maisch, Germany)). The
peptides were eluted from the pre-column using a gradient from
100% phase A (0.1% formic acid aqueous solution) to 40% phase
B (0.1% formic acid, 80%acetonitrile) in 100 min at 200 nl/min
directly on an 8 cm analytical column (50 mm inner diameter,
360 mm outer diameter, ReproSil–Pur C18 AQ 3 mm). Peptides
were analyzed using a data dependent setup where one MS run
was performed in the Orbitrap at a resolution of 60000 FWHM
and five MSMS runs were performed in the linear ion trap. Each
ion selected for MSMS was fragmented using multi-stage
fragmentation for phosphopeptides [20] where the losses of
phosphoric acid from the phosphopeptides were automatically
selected for another round of fragmentation. The resulting
fragment ion spectrum contains product ions from both the
precursor and the neutral loss product, providing more informa-
tion.
Database searching
The fragment ion spectra were processed (smoothing, back-
ground subtraction and centroiding) using the program DTASu-
perCharge (http://msquant.sourceforge.net/). The processed files
were subsequently searched against the human HSL protein
sequence using an in-house Mascot server (version 2.1) (Matrix
Science Ltd., London, UK). The search was performed choosing
trypsin as enzyme. Oxidation (M), N-Acetyl (Protein), Phospho
(STY) and IntactPhospho (STY) were chosen as variable
modification. The data were searched with a peptide mass
tolerance of 65 ppm and a fragment mass tolerance of 60.6
Da. A maximum of one missed cleavage was allowed. Phospho-
peptides were manually evaluated.
HSL activity assays
HSL lipolytic activity was measured against phospholipid-




cerol (TO) and cholesteryl [
14C]oleate (CO). Briefly, labeled and
non-labeled lipid substrates and phosphatidylcholine/phosphati-
dylinositol (3:1) in cyclohexane solutions were dried under at
stream of N2 followed by emulsification by sonication and addition
of 2% BSA (MOME assay) or 5% BSA (TO and CO assays).
Enzymes were diluted to a suitable concentration in 100 mlo f
20 mM potassium phosphate, pH 7.0, 1 mM EDTA, 1 mM DTT
and 0.02% BSA and 100 ml of the emulsified substrate was added
and mixed. Reactions were typically incubated for a period of
30 min at 37uC before the reaction was quenched by the addition
of 3.25 ml of methanol/chloroform/heptane (10:9:7) and 1.1 ml
of 0.1 M potassium carbonate, 0.1 M boric acid pH 10.5. Samples
were then vortexed and centrifuged and the content of released
fatty acids in the upper phase was determined by scintillation
counting. For all assays we confirmed that the reaction velocity
was constant during the 30 min incubation period. The activity
against the soluble para-nitrophenylbutyrate (pNPB) substrate was
Phosphorylation of Human HSL
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of absorbance at 400 nm [21,22,23,24]. In saturation kinetics
experiments activities towards sequentially diluted substrates were
determined as described above. Substrates for TO saturation
curve measurements were prepared by mixing the substrate
emulsion with a solution prepared in exactly the same way but
with no added TO. One unit of enzyme activity is equivalent to
1 mmol of fatty acids released/min at 37uC. Saturation curves
were analyzed by non-linear regression in the GraphPad Prism 5.0
for Mac software package.
Results
Expression and purification of human HSL variants
Five C-terminally His-tagged human HSL variants were
successfully cloned and expressed in Sf9 insect cells using the
baculovirus/insect cell expression system. These comprise a His-
tagged wild type enzyme and variants in which Ser554 is mutated
into alanine (SVA-SS), in which Ser554 is mutated to Glu (SVE-
SS), in which both Ser552 and Ser554 are mutated to alanine
(AVA-SS) and a quadruple mutant in which Ser552, Ser554,
Ser649 and Ser650 are all mutated to Ala (AVA-AA; Table 1). All
protein variants were purified by anion exchange chromatography
followed by nickel affinity chromatography and dialysis. The
purity of the protein was at least 95% as estimated by SDS-PAGE
(Figure 1). Western blot analysis as well as MALDI MS analysis
of tryptic digests confirmed the identity of the purified proteins
(data not shown). The yield of pure protein was 2–5 mg per litre of
insect cell culture. The specific activities of the purified wild type
enzyme against TO, MOME, CO and pNPB were 1.2 U/mg, 23
U/mg, 2.3 U/mg, and 50 U/mg, respectively. Fluorescence
emission spectra between 300 nm and 400 nm were recorded after
excitation at 296 nm. All variants had a maximum emission
wavelength of 335 nm (Figure 2).
Background phosphorylation in insect cells
Incubation of cells with
32PO4
32 showed that wild type HSL is
phosphorylated in Sf9 cells and that this phosphorylation can be
removed by calf intestinal phosphatase (Figure 3A). Dephosphor-
ylation of the wild type protein had no effect on triolein hydrolysis
(Figure 3B). However, in order to exclude any differences in
background phosphorylation between enzyme preparations a
Figure 1. Expression and purification of HSL variants. Lane 1: soluble protein from Sf9 cells containing the wild type enzyme; Lane 2: purified
wild type enzyme; Lane 3: purified SVA-SS variant; Lane 4: purified SVE-SS variant; Lane 5: purified AVA-SS variant; Lane 6: purified AVA-AA variant.
doi:10.1371/journal.pone.0003756.g001
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ments. Background phosphorylation was also present in the AVA-
SS variant but could not be detected in the AVA-AA variant (not
shown). MALDI MS analysis revealed phosphopeptides including
Ser649 and Ser650 (not shown).
Effects of point mutations on the activity of HSL
Mutating Ser554 to alanine (the SVA-SS variant) resulted in a
slight decrease in lipolytic activity. Mimicking the charge effect of
an anti-lipolytic phosphorylation of the basal site by mutating
Ser554 to glutamic acid (the SVE-SS variant) resulted in similar to
wild type activity. Simultaneous mutation of both Ser552 and
Ser554 to alanine (the AVA-SS variant) had no effect on the
activity. However, mutating all four serines, including Ser649 and
Ser650 (the AVA-AA variant) decreased the activity of human
HSL against TO, MOME and CO substrates by 67%, 63% and
60%, respectively. The activity against pNPB also decreased, but
only by 30% compared to wild type HSL (Figure 4).
Kinetic behavior of the wild type enzyme and the AVA-
AA mutant
Both the WT enzyme and the AVA-AA mutant had Michaelis-
Menten-like saturation curves when assayed against increasing
concentrations of TO and pPNB (Figure 5). However, concepts
and methods of enzymology, such as Michaelis-Menten kinetics,
Figure 2. Normalized Trp fluorescence spectra of wild type,
SVA-SS, SVE-SS, AVA-SS and AVA-AA variants of human HSL.
Proteins were excited at 296 nm and emission was measured between
300 and 400 nm. Spectra were smoothened and normalized in
GraphPad Prism 5.0 for Mac. The wavelength of the emission peaks is
335 nm for all five variants.
doi:10.1371/journal.pone.0003756.g002
Figure 3. Phosphorylation status of HSL purified from Sf9 cells.
The wild type enzyme was expressed in the presence of
32P, purified
and dephosphorylated by calf intestinal phosphatase. The samples
were analyzed by autoradiography (A; upper panel), by SDS-PAGE and
Coomassie blue staining (A; lower panel) and by enzymatic assay using
TO as substrate (B).
doi:10.1371/journal.pone.0003756.g003
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homogenous milieus do no apply to lipases acting in heterogenous
reactions systems with two or more phases. For this reason we
have used the terms maximum turnover rate and S0.5, corre-
sponding to the substrate concentration leading to half of the
maximum turnover rate, to describe the kinetic behavior of the
different HSL enzymes. The S0.5 against TO was
0.3060.023 mM for the wild type enzyme and 0.3260.035 mM
for the AVA-AA mutant. The maximum turnover rate for TO was
1.360.028 U/mg for wild type and 0.4260.015 U/mg for AVA-
AA. The S0.5 value for pNPB was 0.1760.018 mM for wild type
and 0.1860.017 mM for AVA-AA. The maximal turnover rate
for pNPB was 6062.2 U/mg for wild type and 3361.1 U/mg for
AVA-AA (Figure 5 and Table 2).
In vitro phosphorylation by PKA
Following inhibition of the phosphatase by 10 mM sodium
orthovanadate, dephosphorylated HSL was phosphorylated by
PKA. Phosphorylation reached its maximum after 30 to 45 min
and the stoichiometry was determined to be 0.2 mol phosphate
per mol protein for wild type HSL. The SVA-SS and SVE-SS
variants in which Ser554 was replaced by alanine and glutamic
acid (the latter to mimic an anti-lipolytic phosphorylation),
respectively, and the AVA-SS variant in which both Ser552 and
Ser554 had been substituted for alanine, were phosphorylated to a
similar degree as wild type HSL. However, the AVA-AA mutant,
where also Ser649 and Ser650 have been replaced by alanine, was
poorly phosphorylated (Figure 6).
MS analysis of TiO2-prepared tryptic peptides of the phos-
phorylated enzymes detected phosphopeptides in all five enzymes.
For the wild type, SVA-SS, SVE-SS and AVA-SS enzymes
phosphorylation was found at the Ser649/Ser650 site. MS/MS
analysis of the respective phosphopeptide suggested that the bulk
of the Ser649/Ser650 site phosphate groups was present on
Ser650 (Figure 7). For the wild type enzyme phosphorylation was
also present on a peptide containing Ser552 and Ser554. For the
SVA-SS mutant phosphorylation was found on Ser552, whereas
no phosphorylation was detected on this site in the SVE-SS
Figure 4. Activities of purified human HSL enzymes. Enzymes were assayed for their activity against TO, MOME and CO under saturated
substrate concentrations. The activity against pNPB was performed with 1 mM pNPB. Data represent the means6standard error of nine assays.
*P,0.05; *** P,0.0005, one way ANOVA.
doi:10.1371/journal.pone.0003756.g004
Figure 5. Saturation curves of the wild type enzyme (N) and the AVA-AA mutant (&) in the TO assay (A) and the pNPB assay (B).
Maximum turnover values were 1.3 U/mg and 0.42 U/mg for wild type and the AVA-AA mutant, respectively in the TO assay. The maximal turnover
rates were 60 U/mg and 33 U/mg for wild type and the AVA-AA mutant respectively in the pNPB assay. The S0.5 values were 0.30 mM and 0.32 mM
for the wild type enzyme and the AVA-AA mutant, respectively in the TO assay. The S0.5 values were 0.17 mM and 0.18 mM for the wild type enzyme
and the AVA-AA mutant respectively in the pNPB assay (see also Table 2).
doi:10.1371/journal.pone.0003756.g005
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all of the five enzymes (Table 3).
Activation of HSL variants by PKA phosphorylation
Dephosphorylated protein was phosphorylated by PKA and
assayed for activity directly afterwards. The activities of the wild
type, SVA-SS, SVE-SS and AVA-SS variants increased by 87%,
91%, 62% and 58 %, respectively, against triolein and, by 22%,
44%, 41% and 37%, respectively, against the diolein analogue
MOME. The activity against CO was increased by 15%, 19% and
21%, respectively for the wild type, SVA-SS and SVE-SS variants.
PKA phosphorylation of the AVA-AA mutant had no effect on its
activity towards any of the tested substrates (Figure 8, A–E).
Because the degree of activation in absolute terms varied from
experiment to experiment, the results shown in Figure 8 are
representative of three to five individual experiments for each
assay. In all experiments the activity of the wild type, SVA-SS,
SVE-SS and AVA-SS variants increased against TO and MOME
and for the wildtype, SVA-SS and SVE-SS variants the activity
also increased against CO. In all experiments the activation
ranged between 50% and 110% for TO, 20% and 45% for
MOME for the four variants and between 5% and 20% for CO
for the wild type, SVA-SS and SVE-SS variants (Figure 8, A–E).
In no experiment was an activation found against the pNPB
substrate.
Kinetic behavior of the PKA-activated wild type enzyme
The kinetic behaviour of the PKA-phosphorylated form of the
wild type enzyme when assayed against increasing concentra-
tions of TO is shown in Fig. 8F. The S0.5 value was
0.7360.13 mM and the maximum turnover rate was
2.360.11 U/mg (Figure 8F and Table 2). Thus, phosphor-
ylation results in an increase in both turnover and substrate
binding with regard to the TO substrate.
Discussion
In this study we used the baculovirus/insect cell system to
generate recombinant human HSL in order to identify the sites
phosphorylated by PKA in vitro and to study their importance for
the enzymatic properties of human HSL. The specific activity of
23 U/mg for the wild type enzyme against a diolein analogue is
well in agreement with that previously reported for His-tagged
human HSL [25]. Kinetic measurements revealed a maximal
turnover rate of 60 U/mg and a S0.5 value of 0.15 mM under our
pNPB assay conditions. These values are different from those
previously published for the human His-tagged enzyme: 1 mM for
K0.5 and 134 U/mg for kcat (kcat was calculated from the data
presented for pNPB activity in [26]). The reason for this apparent
discrepancy is most likely found in the assay conditions employed.
The solubility limit of pNPB is 1 mM in the absence of mechanical
stirring. In the cited work the authors used mechanical stirring,
which we did not, as a way of increasing the solubility of pNPB,
thus increasing both S0.5. and maximal turnover rate.
Mutating Ser554 into either Ala or Glu had little or no effect on
the activity of HSL. Even mutating both Ser552 and Ser554 to Ala
did not alter activity significantly. This is in agreement with a
previous study performed by our group in which mutation of the
corresponding sites in rat HSL (Ser563 and Ser565) was found to
have no effect on the activity [9], and also with another study on
rat HSL reporting that deletion mutants lacking both Ser563 and
Ser565 retained full enzymatic activity [27]. In contrast our result
is in disagreement with a reported total loss of activity towards
lipid substrates upon mutation of Ser563 to Ala and a partial loss
of activity upon mutating Ser565 to Ala in the rat enzyme [11].
This contradiction could be a reflection of differences in activity
regulation between the rat and the human enzymes. However it
should be pointed out that the data presented in our work are
based on purified HSL, whereas the data presented in [9,11] are
based on partially purified enzyme and cell extracts, respectively.
In contrast to the lack of effect of mutating Ser552 and
Ser554 in human HSL, mutating Ser649 and Ser650 to Ala
severely lowered the activity towards lipid substrates. However
the same mutations had a lesser effect on the activity of the
enzyme towards pNPB, indicating that Ser649 and Ser650 are
more important for the turnover of lipid substrates than for the
catalytic reaction as such. Studies of the kinetic behaviour of the
two enzyme variants showed that there was no significant
difference in the S0.5 value towards either the TO substrate or
the low molecular weight ester pNPB; in contrast the maximum
turnover rates for the AVA-AA mutant were 55% and 33% of
those of the wild type enzyme towards pNPB and TO,
Table 2. Properties of purified wild type human HSL and the AVA-AA mutant
Wild type AVA-AA Phosphorylated wild type
Maximum turnover in TO assay 1.360.028 0.4260.015 2.360.11
S0.5 in TO assay 0.3060.023 0.3260.035 0.7360.13
Maximum turnover in pNPB assay 6062.2 3361.1
S0.5 in pNPB assay 0.1760.018 0.1860.017
Units for turnover and S0.5 are U/mg and mM, respectively. Values are listed with 6SEM.
doi:10.1371/journal.pone.0003756.t002
Figure 6. PKA phosphorylation of HSL variants. Purified HSL
variants were dephosphorylated for 1 h with calf intestinal phosphatase
and then rephosphorylated by PKA in the presence of
32P-labeled ATP.
Reactions were subjected to SDS-PAGE and the amount of incorporated
phosphate was determined by scintillation counting of gel bands and
calculation from standards made from the original reactions.
doi:10.1371/journal.pone.0003756.g006
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substrate binding. The reduced activity could be a reflection of
increased rigidity in the AVA-AA mutant, possibly leading to
impaired product release despite unaltered substrate binding.
This would also fit with the finding that the effect on turnover is
significantly lower for pNPB, for which the products are
butyrate and para-nitrophenol, than for TO, for which the
products are oleate and diolein. The binding of a large oleate
molecule by van der Waals’ interactions would be expected to
be stronger than that of a butyrate.
Differential effects of phosphorylation on lipolytic and non-
lipolytic activity have previously been observed in experiments
where limited proteolysis of recombinant rat HSL abolished
activity against lipid substrates, but had a markedly lower effect on
the activity towards pNPB [28]. Our results are also in agreement
with studies where HSL was inhibited by an esterase inhibitor in
Figure 7. MS/MS spectrum of the mono-phosphorylated RSSQGATQMPLYSSPIVK peptide comprising both Ser649 and Ser650.
Human HSL phosphorylated by PKA was digested with trypsin and phosphopeptides were isolated using TiO2. The isolated peptides were subjected
to MS analysis as described in the experimental procedures section. Shown is the MS/MS spectrum of a doubly charged precursor ion (m/z=1024.4
Da) corresponding to the peptide RSSQGATQMPLYSSPIVK (with Q4 deamidated, M9 oxidized and either S2 or S3 phosphorylated). The 943.50 Da
peak corresponds to the selected parent ion with the loss of phosphate and methanesulfenic acid. From the y ion series (for instance y12 at 1379.42
Da and y15 at 1636.51 Da), it can clearly be seen that T7, S13 and S14 are not phosphorylated. The large peak at 1803.63 Da corresponds to the y16
ion from a peptide phosphorylated on S3 and would not be present if S2 was the only phosphorylation site. The smaller peak at 1723.65 Da, on the
other hand, corresponds to the y16 ion containing no phosphoserine/threonine at all. The presence of both these peaks indicates that the parent ion
consists of a mixture of tryptic peptides phosphorylated on S2 or S3. However, the peak at 1803.63 Da is derived from a fragment containing
phosphate while the peak at 1723.65 Da is derived from the corresponding unphosphorylated fragment. All other things being equal, an
unphosphorylated fragment would be expected to ionize better and give a stronger signal than the corresponding phosphorylated fragment. Thus,
the observation that the peak at 1803.63 Da is so much larger than the peak at 1723.65 Da strongly indicates that the degree of phosphorylation of
S3 is much higher than that of S2.
doi:10.1371/journal.pone.0003756.g007
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lid covering the actual active site [25]. However, our results do not
rule out the possibility of a lid controlling how tightly lipids are
bound to the enzyme.
By employing
32P-labeling during the expression of human HSL
in the baculovirus/insect cell system, we showed that HSL purified
from Sf9 cells is partly phosphorylated. MS analysis of TiO2-
enriched tryptic digests of the wild type enzyme revealed
phosphopeptides containing Ser649 and Ser650 (not shown).
The stoichiometry of the background phosphorylation was not
determined. However, the observation that prior dephosphoryla-
tion of purified human HSL by calf intestinal phosphatase had no
effect on the activity of the wild type enzyme (Figure 2B), suggests
that the background phosphorylation is quantitatively low. The
unexpected discovery that HSL is phosphorylated on biologically
relevant sites by insect cells indicates that these cells contain active
PKA homologues. However, as indicated by our results, this has
no significance for enzymatic activity. In mammalian cells HSL is
regulated by several kinases and as a result HSL activity undergoes
significant modification, as previously shown for several tissues
[12,29,30]. Thus, even though the actual in vivo stochiometry of
HSL phosphorylation has never been established, it is evidently
higher in mammalian cells than in insect cells.
Upon in vitro phosphorylation by PKA, 0.2 mol phosphate per
mol of HSL was incorporated. This level was the same for all
variants, except for the AVA-AA mutant lacking Ser649 and
Ser650, which only showed trace amounts of incorporated
phosphate. MS analysis revealed phosphorylation of several sites.
MS/MS analysis of the peptide containing Ser649/Ser650
(RSSQGATQMPLYSSPIVK) suggested that the major part of
the phosphorylation of this peptide was present on Ser650 rather
than Ser649. This is somewhat in disagreement with our previous
work on rat HSL, where phosphopeptide mapping followed by
radiosequencing of HSL isolated from isoproterenol-stimulated
adipocytes revealed two types of phosphopeptides, a monopho-
sphorylated variant with phosphate on Ser660 and a dipho-
sphorylated peptide with phosphate on both Ser659 and Ser660
[9]. It is possible that species differences account for these
apparent discrepancies. However, it should be pointed out that
Ser659 in rat HSL (Ser649 in human HSL) is not an optimal PKA
consensus site and that previous results from our lab suggested that
Ser659 is phosphorylated at a slower rate than Ser660 [9]. In vivo
evidence for phosphorylation of Ser650 and Ser552 in human
HSL has been provided by several studies. Increased levels of
cyclic AMP as well as the onset of exercise increase phosphory-
lation of Ser650 in human skeletal muscle, whereas phosphory-
lation of Ser552 and Ser554 is unchanged under these conditions
[13]. However it was reported in a recent study that both Ser552
and Ser650 were phosphorylated in response to b-adrenergic
stimulation in 3T3-L1 adipocytes and after the onset of exercise in
Table 3. Phosphorylated peptides in PKA-treated HSL
variants
Position Peptide sequence Found in variant
510–517 RDpTALLLR All
552–571 p[SVS]EAALAQPQGPLGTDSLK WT
648–665 RpSSQGATQMPLYSSPIVK WT, SVA-SS, SVE-SS and AVA-SS
648–665 RpSSQGATQMPLYSSPIVK WT, SVA-SS, SVE-SS and AVA-SS
552–571 pSVAEAALAQPQGPLGTDSLK SVA-SS
doi:10.1371/journal.pone.0003756.t003
Figure 8. Activities of dephosphorylated (2) and rephosphorylated (+) human HSL variants. Purified HSL variants were
dephosphorylated by calf intestinal phosphatase and then phosphorylated by PKA and assayed against TO, MOME, CO and pNPB under saturated
substrate concentrations (panels A–E). Panel F shows the TO assay saturation curve of PKA phosphorylated wild type HSL. Data represents
means6standard error of triplicate assays of an experiment that is representative of three to five independent experiments. *P,0.05; *** P,0.0005,
unpaired t test. The maximal turnover rate and S0.5 values of the phosphorylated wildtype enzyme was 2.3 U/mg and 0.72 mM, respectively (panel F).
doi:10.1371/journal.pone.0003756.g008
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phosphorylation of Ser650 and Ser552 might be due to the action
of different kinases, which is also reflected in our in vitro results.
MS analysis showed that the SVA-SS mutant was phosphor-
ylated on Ser552, whereas this was not the case for the SVE-SS
mutant, suggesting that the charged Glu554 in this mutant
exerts a negative effect on subsequent phosphorylation of
Ser552 by PKA. This is expected on the basis of previous
work showing that phosphorylation of the site corresponding to
Ser554 in human HSL prevents subsequent phosphorylation of
the site corresponding to Ser552 by PKA, indicating that
phosphorylation of Ser554 plays an antilipolytic role [3,4].
However, as the SVA-SS, SVE-SS and AVA-SS variants were
all activated against TO it seems that any interaction between
Ser552 and Ser554 (Ser563 and Ser565 in rat HSL) only has
relevance in vivo.
Phosphorylation by PKA increased the activity of the wild
type human HSL against the triglyceride substrate TO by 87%.
This is in line with reported data for both rat and human HSL
[8,31] and the level of activation was similar for all investigated
HSL variants, except for the AVA-AA mutant, which showed no
activation in response to phosphorylation by PKA. Phosphor-
ylation also increased activity towards the diglyceride substrate
MOME by at least 22% for all variants except AVA-AA. We
also recorded a slight activation against CO. To our knowledge
this is the first time activation towards a diglyceride substrate has
been detected in vitro. With regard to the activation against CO,
studies in which partially purified HSL preparations from
adrenal cortex and corpus luteum were used have suggested that
PKA phosphorylation increases the activity towards cholesteryl
ester substrates [32,33]. Analysis of the kinetic behavior of the
wild type enzyme against TO revealed that not only did
phosphorylation increase maximum turnover rate, but it also
increased S0.5 compared to the non-phosphorylated enzyme.
This is logical in the view of the known translocation of HSL to
the lipid droplet after stimulation of lipolysis. Once HSL is
placed in the hydrophobic milieu in the droplet it will be in an
environment saturated with substrate and activity will not
benefit from a strong substrate interaction, but rather from an
increased release rate of product molecules. Considering that the
S0.5.values of AVA-AA for pNPB and TO is similar to those of
the non-phosphorylated wild type enzyme, it seems likely that
the conformational changes induced by the phosphorylation
event affect other structural features than those affected by the
mutation of Ser649 and Ser650 to Ala. An explanation for this
phenomenon is not obvious and underlines the need for a crystal
structure of HSL. It could be speculated that the HSL molecule
following phosphorylation by PKA adopts a more open and
flexible conformation rendering the enzyme surface more
hydrophobic enabling a freer access to the lipid binding site in
return for weaker binding, which in turn is not rate limiting
inside the lipid saturated environment of a lipid droplet.
Thus in vitro activation of HSL might reflect a fine-tuning of the
enzyme for the lipid saturated environment of lipid droplets and is
mediated solely by phosphorylation of Ser649 and Ser650 by
PKA. In contrast, activation of HSL in vivo relies on the
phosphorylation of several sites, and is a result of a complex
interplay between HSL, PKA, perilipin and most likely other key
players, such as phosphatases, additional kinases and lipid droplet
associated proteins, leading to a more than 50-fold increase in the
lipolytic rate. Previous work on rat HSL has shown that Ser565,
Ser659 and Ser660 (corresponding to Ser554, Ser649 and Ser650
in human HSL) are all determinants of the translocation event
[10], whereas the role of Ser563 remains elusive.
In conclusion, we have demonstrated that activation of human
HSL against lipid substrates in response to phosphorylation by
PKA in vitro is governed by Ser649 and Ser650 and that this
activation involves alterations in the kinetic behavior of the
enzyme with increases in both maximum turnover rate and S0.5.
Moreover, mutation of Ser649 and Ser650 results in loss of
lipolytic activity, with lesser effect on non-lipolytic activity. Taken
together, this suggests that Ser649 and Ser650 are located in the
vicinity of a lipid binding region and that phosphorylation by PKA
controls the accessibility of this region.
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